Zusammenfassung
Das Auftreten urologischer Erkrankungen im Alter ist ein zunehmendes, klinisches Problem, da die Lebenserwartung steigt und mit zunehmenden Alter die Inzidenz urologischer Erkrankungen zunimmt. Es fehlen aber ausreichende Daten zur Beurteilung verschiedener Therapieverfahren bezogen auf Patienten über 70 Jahre [42]. Das Alter an sich stellt keinen eigenen Vorhersagewert für ein Behandlungsergebnis dar. Viel wichtiger erscheint es, ältere Patienten hinsichtlich ihres funktionellen Status, ihrer Komorbidität, ihrer sozioökonomischen Verhältnisse, ihrer kognitiven und emotinalen Fähigkeiten sowie ihres Ernährungszustandes einzuschätzen.
Abstract
Urological illnesses in the elderly are a growing clinical problem because as life expectancy increases so does the prevalence of such illnesses. However, sufficient data for judging the various possible therapies are lacking for patients over the age of 70. Age itself does not have enough predictive value for the determination of the best treatment. It seems more important to estimate the functional and socio-economic status, comorbidity, and the cognitive and emotional abilities of elderly patients as well as their nutritional intake.
Literatur
Gomolin ICH, Mc Cue JD (2000) Urinary tract inferction in the elderly patient. Infections in Urology 13 (Suppl): 7
Baldassare JS, Kaye D (1991) Special problems of urinary tract infection in the elderly. Med Clin North Am 75: 375
Nicolle LE (1999) Urinary infections in the elderly: symptomatic or asymptomatic? Int J Antimicrobiol Agents 11: 265
Bonadio M, Meini M, Spitalery P, Gigli C (2001) Current microbiological and clinical aspects of urinary tract infections. Eur Urol 40: 439
Abrutyn E, MosseyJ, Berlin JA, Boscia J, Levision M, Pitsakis P, Kaye D (1994) Does asymptomatic bacteriuria predict mortality and does antimicrobial treatment reduce mortality in elderly ambulatory women? Ann Intern Med 120: 827
Ronald A, Ludwig E (2000) Urincary tract infections in adults with diabetes. Int J Antimicr Agents 17: 287
Geerlings SE, Hoepelman Al (1999) Immunodysfunction in ptients with diabetes mellitus (DM). FEMS Immuno Med. Microbiol 26: 259
Zimakoff J, Pontoppidan B, Lars SO, Stickler DJ (1993) Management of urinary bladder-function in Danish hospitals, nursing homes and home care. J Hosp Infect 24: 183
Liedl B (1999) Katheterassoziierte Harnwegsinfektionen. In: Hofstetter A (Hrsg) Urogenitale Infektionen. Springer, Berlin Heidelberg New York Tokio, S 241–263
Schmucker DL (2001) Liver function and phase I drug metabolism in the elderly: a paradox. Drugs Aging 18: 837
Naber KG, Fünfstück R, Hofstetter A, Brühl P, Hoyme U (2000) Empfehlungen zur antimikrobiellen Therapie von Infektionen der Nieren und des Urogenitaltraktes bei Erwachsenen. Chemother J 6: 193
Vahlensieck W Jr (1999) Prophylaxemaßnahmen bei rezidivierenden Harnwegsfektionen. In: Hofstetter A (Hrsg) Urogenitale Infektionen. Springer, Berlin Heidelberg New York Tokio, pp 215–239
Mack DJ, Smart L, Girdwood A, Scott PJW, Fulton JD, Erwin L (1993) Infeciton prophylaxis with lactulose. Age Ageing 22 (Suppl 2): 8
Raz R, Stamm WE (1993) A controlled trial of intravaginal estriol in post-menopausl women with recurrent urinary tract infections. N Engl. Med J 329: 753
Hampel C, Wienhold D, Benken N, Eggersmann C, Thüroff JW (1997) Definition of overactive bladder and epidemiology of urinary incontinence. Urology 50 (Suppl 6A): 4–14
Diokno AC, Brock BM, Brown MB, Herog AR (1996) Prevalence of urinary incontinence and other urological symptoms in the noninstitutionalized elderly. J Urol 136: 1022–1025
Ouslander JG (1992) Geriatric urinary incontinence. Dis Mon 38: 65–149
Elbadawi A, Hailemariam S, Yalla SV, Resnick NM (1997) Structural basis of geriatric voiding dysfunction. VII. Prospektive ultrastructural/urodynamic evaluation of its natural evolution. J Urol 157: 1814–1822
Elbadawi A, Diokno AC, Millard RJ (1998) The aging bladder: Morphology and urodynamics. World J Urol 16 (Suppl 1): 10–34
Lin AT, Yang CH, Chand LS (1997) Impact of aging on rat urinary bladder fatigue. J Urol 157: 1990–1994
Melchior HJ, de Geeter P (2000) Miktionsstörungen und Harninkontinenz. Diagnostik und Therapie in der (haus)ärztlichen Praxis. pmi, Frankfurt
Anderson JB, Roehrborn CG, Schalken JA, Emberton M (2001) The progression of benign prostatic hyperplasia: examining the evidence and determing the risk. Eur Urol 39: 390–399
Jacobsen SJ, Girman CJ, Lieber MM (2001) Natural history of benign prostatic hyperplasia. Urology 58 (Suppl 1) 5–16
Roehrborn CG, Malice M, Cook TJ, Girman CJ (2001) Clinical predictors of spontaneous acute urinary retention in men with LUTS and clinical BPH: a comprehensive analysis of the pooled placebo groups of several large clinical trials. Urology 58: 210–216
Arrighi HM, MetterEJ, Guess HA, Fozzard JL (1991) Natural history of benign prostatic hyperplasia and risk of prostatectomy. The Baltimore Longitudinal Study of Aging. Urology 38 (Suppl 1): 4–8
Berges RR, Pientka L, Hofner K, Senge T, Jonas U (2001) Male lower urnary tract symptoms and related health care seeking in Germany. Eur Urol 39: 682–687
Blanker MH, Bohnen AM, Groeneveld FPMJ, Bernsen RMD, Prins A, Bosch JLHR (2000) Normal voiding patterns and determinants of increased diurnal and nocturnal voiding frequency in elderly men. J Urol 164: 1201–1205
Jacobsen SJ, Jacobson DJ, Gierman CJ, Roberts RO, Rhodes T, Guess HA, Lieber MM (1999) Treatment for benign prostatic hyperplasia among community dwelling men: the Olmsted County study of urinary symptoms and health status. J Urol 162: 1301–1306
De Rijke JM, Schouten LJ, Hillen HFP et al. Cancer in the very elderly dutch population. Cancer 89: 1121–1133
Becker (2002) Epidemiologie. In: Höffken K, Kolb G, Wedding U (Hrsg) Geriatrische Onkologie. Springer, Berlin Heidelberg New York Tokio, S 1–28
Cohen HJ (1994) Biology of aging as related to cancer. Cancer 74: 2092–2100
Hart RW, Turturro A (1992) Overview of cancer an aging: a mechanistic perspective. Exp Gerontol 27: 441–445
Lance RG, Grossmann HB (2001) Chemotherapy in the elderly. Sem Urol Oncol 19: 51–55
Figueroa Ajm, Stein JP, Dickinson M et al. (1998) Radical cystectomy for elderly patients with bladder carcinoma—an updated experience in 404 patients. Cancer 83: 141–147
Middleton AW (1987) Radical prostatectomy for carcinoma in men more than 69 years old. Cancer Control 7: 548–556
Dillioglugil O, Leibman BD, Leibman NS et al. (1997) Risk factors for complications and morbidity after radical prostatectomy. J Urol 157: 1760–1767
Alberson PC, Fryback DG, Storer BE, Kolon TF, Fine J (1996) The impact of co-morbidity on life expectancy among men with localized prostate cancer. J Urol 156: 127–132
Severson RK, Montie JE, Porter AT, Demers RY, Recent trends in incidence and treatment of prostate cancer among elderly men. J Natl Cancer Inst 87: 532–534
Kanamaru H, Arai Y, Akino H et al. (1999) Long-term treatment results of elderly patients with prostate cancer in Japan: an analysis of prognostic factors. Jpn J Clin Oncol 29: 151–155
Lichtmann SM, Villani G (2000) Chemotherapy in the elderly: Pharmacologic considerations. Cancer Control 7: 548–556
Balducci L, Hardy CL, Lyman GH (2000) Hematopoetic reserve in the older cancer patient: clinical and economic considerations. Cancer Control 7: 539–547
Drach GW, Griebling TL (2003) Geriatric Urology. J Am Soc Geriatr Med 51: S355–S358
Interessenkonflikt:
Der korrespondierende Autor versichert, dass keine Verbindungen mit einer Firma, deren Produkt in dem Artikel genannt ist, oder einer Firma, die ein Konkurrenzprodukt vertreibt, bestehen.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wolff, J.M. Urologische Erkrankungen im Alter. Urologe [A] 43, 916–921 (2004). https://doi.org/10.1007/s00120-004-0636-0
Issue Date:
DOI: https://doi.org/10.1007/s00120-004-0636-0